CareTrust REIT, Inc. (CTRE) SEC Filings & Earnings Calls
EquiReason read 16 CareTrust REIT, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-02 — CareTrust REIT acquired 24 care homes in the UK for ~£576M ($764M) with potential for 21 more, expanding international portfolio..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 8.7B
- P/E TTM
- 22.9
- Dividend yield
- 4.0%
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
2 Oct 20268-K · 2.01, 7.01CareTrust REIT acquired 24 care homes in the UK for ~£576M ($764M) with potential for 21 more, expanding international portfolio.acquisitionopen
Figures in the filing · each found in the filing text
| Acquired Properties (In-Development) · UK Care Homes · Q3-2026 | 21 | |
| Purchase Price (Completed) · UK Care Homes · Q3-2026 | $576M | |
| Purchase Price (In-Development) · UK Care Homes · Q3-2026 | $504M |
Risks flagged
Completion risk for in-development properties and regulatory approvals.
“In-Development Properties are currently under development and subject to regulatory approval.”
Lease-up and NOI yield risk for acquired properties.
“Risk that stabilization and anticipated net operating income yields are not achieved.”
6 Aug 202610-QCareTrust REIT reported strong Q2 2026 results with rental income up 47% YoY, 100% rent collection, and significant capital raising activity.earningsopen
Figures in the filing · each found in the filing text
| Net income · Q2-2026 | $32M | |
| Operating cash flow · H1-2026 | $225M | +31% y/y |
| Investment pipeline · H1-2026 | $424M | |
| Offering per price share · Q2-2026 | $40.23 |
Risks flagged
Interest rate and capital cost pressure
“Higher interest rates and market volatility have also increased our costs of capital to finance acquisitions and increased our borrowing costs.” · word for word
Tenant financial stress from regulatory and cost pressures
“The step-up may further pressure operating costs for our California-based tenants and borrowers, which could adversely affect their financial condition and ability to meet their obligations to us.” · word for word
Potential future Medicare payment reductions
“While the RFI did not result in specific rate changes for fiscal year 2027, it indicates CMS may pursue future recalibrations to PDPM that could reduce per-beneficiary Medicare payments to SNFs in fiscal years beyond fiscal year 2027.” · word for word
6 Aug 20268-K · 2.02, 7.01Net income $89M; Normalized FFO $120M; Normalized FAD $118M; Guidance: Normalized FFO $2.03-$2.06 per share; Normalized FAD $2.01-$2.04 per shareearningsopen
Figures in the filing · each found in the filing text
| Net income · Q2-2026 | $89M | |
| Normalized FFO · Q2-2026 | $120M | |
| Normalized FAD · Q2-2026 | $119M | |
| Investment activity closed · Q2-2026 | $900M | |
| Blended stabilized yield · Q2-2026 | 8.9% |
Guidance
Normalized FFO $2.03-$2.06 per share; Normalized FAD $2.01-$2.04 per share
Raised 2026 guidance on strong investment activity and pipeline.
Risks flagged
High leverage on credit facility; $595M drawn on $1.2B facility.
“$595 million in borrowings outstanding on its $1.2 billion unsecured revolving credit facility” · word for word
21 May 20268-K · 8.01Additional shares sold via option 1,875,000; Price per share $40.23open
Figures in the filing · each found in the filing text
| Additional shares sold via option · Q2-2026 | 1,875,000 | |
| Price per share · Q2-2026 | $40.23 |
Risks flagged
Dilution from additional share issuance; forward sale structure may delay dilution but still dilutive.
“1,875,000 additional shares sold via forward sale.”
20 May 20268-K · 8.01Shares offered 12,500,000; Offering price per share $40.23open
Figures in the filing · each found in the filing text
| Shares offered | 12,500,000 | |
| Offering price per share | $40.23 |
Risks flagged
Potential dilution from forward sale if physically settled; share count increase of up to 14.375M shares.
“Forward sale agreements for 12.5M shares plus option for 1.875M shares.”
7 May 202610-QRental income $114M (+59% y/y); Net cash provided by operating activities $90M (+27% y/y); Acquisitions $212Mopen
Figures in the filing · each found in the filing text
| Rental income · Q1-2026 | $114M | +59% y/y |
| Net cash provided by operating activities · Q1-2026 | $90M | +27% y/y |
| Acquisitions · Q1-2026 | $212M | |
| Dividends paid · Q1-2026 | $75M | +38% y/y |
Risks flagged
California Minimum Wage Pressure on Tenants
“The upcoming June 2026 step-up may further pressure operating costs for our California-based tenants and borrowers, which could adversely affect their financial condition and ability to meet their obligations to us.” · word for word
CMS PDPM Recalibration Risk
“While the RFI does not propose specific rate changes, it indicates CMS may pursue future recalibrations to PDPM that could reduce per-beneficiary Medicare payments to SNFs in fiscal years beyond fiscal year 2027.” · word for word
Macroeconomic and Tariff Uncertainty
“Recent macroeconomic conditions, particularly market uncertainty, immigration restrictions and changes to immigration enforcement policy, changes to the U.S. healthcare system, shutdown of the federal government, inflation (including higher supply costs and shortages), effects of global tariffs, elevated interest rates and related changes to consumer spendin” · word for word
7 May 20268-K · 2.02, 7.01Net income $80M; Normalized FFO $107M; Normalized FAD $108M; Guidance: Normalized FFO guidance midpoint $2.02 (14.8% YoY growth); Normalized FAD guidance midpoint $2.00 (13.6% YoY growth).earningsopen
Figures in the filing · each found in the filing text
| Net income · Q1-2026 | $80M | |
| Normalized FFO · Q1-2026 | $107M | |
| Normalized FAD · Q1-2026 | $108M | |
| Investment activity closed · Q1-2026 | $245M | |
| Blended stabilized yield · Q1-2026 | 8.8% | |
| Net Debt to Annualized Normalized Run Rate EBITDA · Q1-2026 | $0.60 | |
| Quarterly dividend per share · Q1-2026 | $0.39 | +16% y/y |
| Normalized FFO per diluted share guidance midpoint · FY2026 | $2.02 | +15% y/y |
| Normalized FAD per diluted share guidance midpoint · FY2026 | $2.00 | +14% y/y |
| Investment activity closed since quarter end · Q2-2026 | $864M |
Guidance
Normalized FFO guidance midpoint $2.02 (14.8% YoY growth); Normalized FAD guidance midpoint $2.00 (13.6% YoY growth).
Increased 2026 guidance across all key metrics, driven by strong investment activity, high yields, and robust pipeline. Management expresses high confidence in continued growth.
Risks flagged
Guidance assumes no new investments beyond year-to-date, which may be conservative given strong pipeline.
“Guidance assumes no new investments, loans, or dispositions beyond those made year-to-date.”
Exposure to GBP:USD exchange rate fluctuations due to UK investments.
“No material change in the GBP:USD spot exchange rate.” · word for word
13 Mar 2026DEF 14ACareTrust REIT filed its definitive proxy statement (DEF 14A) for the 2026 annual meeting, disclosing executive compensation details, board nominations, and pay-for-performance alignment.open
Figures in the filing · each found in the filing text
| Capital Deployment · FY2025 | $1.76B | |
| Market Capitalization · 2025-12-31 | $8.00B | +77% y/y |
| Net Debt to Normalized Run-Rate EBITDA (average quarterly) · FY2025 | $0.89 | |
| Three-Year Total Shareholder Return · 2023-2025 | 119.1% | |
| Net Income · FY2025 | $321M | |
| Normalized Funds From Operations (NFFO) · FY2025 | $360M | |
| Normalized Funds Available for Distribution (NFAD) · FY2025 | $360M |
18 Feb 20268-K · 1.01CareTrust REIT entered into a new equity distribution agreement for an at-the-market offering of up to $1B of common stock, replacing prior ATM program; proceeds for general corporate purposes including acquisitions and debt repayment.open
Figures in the filing · each found in the filing text
| ATM offering amount | $1.00B |
Risks flagged
Potential dilution from equity issuance.
“Up to $1B in common stock may be issued.”
12 Feb 20268-K · 2.02, 7.01Net income attributable to CareTrust $320M (+96% y/y); Normalized FFO attributable to CareTrust $360M (+17% y/y); Normalized FAD attributable to CareTrust $360M (+14% y/y); Guidance: Normalized FFO guidance midpoint $1.925, up 9.4% YoYearningsopen
Figures in the filing · each found in the filing text
| Net income attributable to CareTrust · FY2025 | $321M | +96% y/y |
| Normalized FFO attributable to CareTrust · FY2025 | $360M | +17% y/y |
| Normalized FAD attributable to CareTrust · FY2025 | $360M | +14% y/y |
| Investment activity closed · FY2025 | $1.80B | |
| Blended stabilized yield · FY2025 | 8.6% | |
| Net Debt to Annualized Normalized Run Rate EBITDA · Q4-2025 | $0.70 | |
| Quarterly dividend per share · Q4-2025 | $0.34 | |
| Payout ratio on Normalized FAD · Q4-2025 | 73.0% | |
| Investment pipeline · 2026 | $500M | |
| Cash on hand · 2026-02-11 | $100M |
Guidance
Normalized FFO guidance midpoint $1.925, up 9.4% YoY
2026 guidance raised with Normalized FFO and FAD midpoints up 9.4% YoY, supported by strong pipeline and fortress balance sheet.
Risks flagged
Concentration in healthcare real estate sector, though diversified with UK and SHOP.
“strategic additions of two new growth engines of UK Care Homes and SHOP” · word for word
Interest rate sensitivity could impact cap rates and investment yields.
“Net Debt to Annualized Normalized Run Rate EBITDA of 0.7x ... below target leverage range of 4.0x to 5.0x” · word for word
12 Feb 202610-KRevenue from properties leased to third-party tenants and SHOP $369M (+62% y/y); Skilled nursing triple-net occupancy 76; Senior housing triple-net occupancy 86open
Figures in the filing · each found in the filing text
| Revenue from properties leased to third-party tenants and SHOP · total · FY2025 | $369M | +62% y/y |
| Skilled nursing triple-net occupancy · skilled_nursing_triple_net · FY2025 | 76.0% | |
| Senior housing triple-net occupancy · senior_housing_triple_net · FY2025 | 86.0% | |
| Total owned properties · total · FY2025 | 410 | |
| Total beds/units · total · FY2025 | 37,898 | |
| Annualized contractual rental income from Ensign Master Leases · ensign · FY2025 | $92M | |
| Total acquisitions (purchase price) · total · FY2025 | $1.57B | |
| Net gain on sale of real estate · total · FY2025 | $32M | |
| Interest income from other real estate related investments · other_investments · FY2025 | $79M | +63% y/y |
| Interest income from financing receivable · financing_receivable · FY2025 | $11M | +1039% y/y |
Risks flagged
Tenant concentration risk
“Ensign accounted for 23% of total annualized contractual rental income as of December 31, 2025.”
Macroeconomic headwinds
“recent macroeconomic conditions, particularly market uncertainty, immigration restrictions and changes to immigration enforcement policy, changes to the U.S. healthcare system, shutdown of the federal government, declining consumer sentiment, inflation (including higher supply costs and shortages), effects of global tariffs, elevated interest rates and relat” · word for word
Regulatory and reimbursement risk
“state level Medicaid reimbursement rate reductions and minimum wage increases could lead to increased costs” · word for word
SHOP platform operational risk
“We are dependent on the ability of our third party managers to successfully manage and operate our SHOP communities” · word for word
5 Nov 202510-QCareTrust REIT reported strong Q3 2025 results with 21% QoQ rental income growth, driven by the Care REIT Acquisition, and 100% rent collection.earningsopen
Figures in the filing · each found in the filing text
| Rental income · Q3-2025 | $104M | |
| Net income (loss) attributable to noncontrolling interests · Q3-2025 | $29000.00 | |
| Offering price per share · 2025-08-14 | $32.00 | |
| Operating cash flow · 9M-2025 | $273M | +62% y/y |
Risks flagged
Medicaid Reimbursement Risk
“In Idaho, the Department of Health and Welfare enacted a 4% across-the-board rate cut in response to an $80 million budget shortfall. In North Carolina, the Department of Health and Human Services reduced provider reimbursement rates by 3% to 10%, effective October 1, 2025, following a $319 million funding gap in the state’s Medicaid rebase.” · word for word
Interest Rate Risk
“Higher interest rates and market volatility have also increased our costs of capital to finance acquisitions and increased our borrowing costs.” · word for word
Integration Risk
“the intended benefits of our acquisition of Care REIT plc may not be realized, and we will be subject to additional risks from our investment in Care REIT and any other international investments” · word for word
5 Nov 20258-K · 2.02, 7.01Net Income $75M (+67% y/y); Normalized FFO $95M (+18% y/y); Normalized FAD $93M (+13% y/y); Guidance: Net income $1.41-$1.42, normalized FFO $1.76-$1.77, normalized FAD $1.76-$1.77 per shareearningsopen
Figures in the filing · each found in the filing text
| Net Income · Q3-2025 | $75M | +67% y/y |
| Normalized FFO · Q3-2025 | $95M | +18% y/y |
| Normalized FAD · Q3-2025 | $93M | +13% y/y |
| Investment Activity · Q3-2025 | $59M | |
| Investment Pipeline · Q3-2025 | $600M | |
| Dividend per Share · Q3-2025 | $0.34 | |
| Net Debt to EBITDA · Q3-2025 | $0.42 |
Guidance
Net income $1.41-$1.42, normalized FFO $1.76-$1.77, normalized FAD $1.76-$1.77 per share
Guidance updated upward reflecting strong investment activity and earnings growth.
Risks flagged
Guidance updated due to duration gap between equity raise and capital deployment; G&A at high end.
“Updated guidance is primarily the result of a duration gap between our equity raise and deploying that capital.” · word for word
CareTrust REIT, Inc. — questions
- What did CareTrust REIT, Inc. file recently?
- 16 SEC filings in the last 12 months. Latest: 8-K on 2026-10-02 — CareTrust REIT acquired 24 care homes in the UK for ~£576M ($764M) with potential for 21 more, expanding international portfolio.
Every figure on this page comes from CareTrust REIT, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.